PubRank

Jean-Marie Pagès

Author PubWeight™ 80.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 2011 2.46
2 The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob Agents Chemother 2002 1.92
3 Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2007 1.50
4 Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy. J Antimicrob Chemother 2007 1.43
5 Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J Clin Microbiol 2004 1.30
6 Chloramphenicol and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 2005 1.29
7 Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J 2003 1.28
8 Membrane permeability and regulation of drug "influx and efflux" in enterobacterial pathogens. Curr Drug Targets 2008 1.26
9 Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother 2003 1.26
10 Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species. Antimicrob Agents Chemother 2009 1.26
11 Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob Agents Chemother 2010 1.25
12 mar Operon involved in multidrug resistance of Enterobacter aerogenes. Antimicrob Agents Chemother 2002 1.23
13 The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob Agents Chemother 2004 1.20
14 Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 2008 1.20
15 Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region. Biochem J 2002 1.18
16 Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 2005 1.14
17 Implication of porins in beta-lactam resistance of Providencia stuartii. J Biol Chem 2010 1.14
18 Identification of an OprD homologue in Acinetobacter baumannii. J Proteome Res 2005 1.12
19 Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem Biophys Res Commun 2002 1.11
20 Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov 2006 1.09
21 Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005 1.08
22 Structural and functional study of the phenicol-specific efflux pump FloR belonging to the major facilitator superfamily. Antimicrob Agents Chemother 2005 1.08
23 Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria. FEBS Lett 2011 1.06
24 Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS One 2008 1.06
25 Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes. Biochem Biophys Res Commun 2004 1.05
26 Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int J Antimicrob Agents 2008 1.04
27 Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun 2003 1.04
28 Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation. J Antimicrob Chemother 2006 1.04
29 How beta-lactam antibiotics enter bacteria: a dialogue with the porins. PLoS One 2009 1.04
30 Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics. Phytomedicine 2012 1.03
31 Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother 2010 0.99
32 Beta-lactam screening by specific residues of the OmpF eyelet. J Med Chem 2005 0.99
33 Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates. Curr Drug Targets 2006 0.98
34 A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int J Antimicrob Agents 2003 0.97
35 Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains. Antimicrob Agents Chemother 2004 0.96
36 Squalamine: an appropriate strategy against the emergence of multidrug resistant gram-negative bacteria? PLoS One 2008 0.95
37 An instrument-free method for the demonstration of efflux pump activity of bacteria. In Vivo 2006 0.94
38 Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. FEBS Lett 2004 0.94
39 Toward screening for antibiotics with enhanced permeation properties through bacterial porins. Biochemistry 2010 0.94
40 Functional refolding of the Campylobacter jejuni MOMP (major outer membrane protein) porin by GroEL from the same species. Biochem J 2004 0.93
41 Omp35, a new Enterobacter aerogenes porin involved in selective susceptibility to cephalosporins. Antimicrob Agents Chemother 2004 0.93
42 An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int J Antimicrob Agents 2012 0.92
43 Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria. Med Chem 2008 0.92
44 An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob Agents Chemother 2007 0.92
45 The eefABC multidrug efflux pump operon is repressed by H-NS in Enterobacter aerogenes. J Bacteriol 2005 0.92
46 Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method. In Vivo 2011 0.91
47 Environmental regulation of Campylobacter jejuni major outer membrane protein porin expression in Escherichia coli monitored by using green fluorescent protein. Appl Environ Microbiol 2002 0.91
48 Quinazoline derivatives are efficient chemosensitizers of antibiotic activity in Enterobacter aerogenes, Klebsiella pneumoniae and Pseudomonas aeruginosa resistant strains. Int J Antimicrob Agents 2010 0.88
49 Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother 2009 0.87
50 Efflux pumps of gram-negative bacteria: genetic responses to stress and the modulation of their activity by pH, inhibitors, and phenothiazines. Adv Enzymol Relat Areas Mol Biol 2011 0.87
51 Antibiotic transport in resistant bacteria: synchrotron UV fluorescence microscopy to determine antibiotic accumulation with single cell resolution. PLoS One 2012 0.87
52 Colicins, spermine and cephalosporins: a competitive interaction with the OmpF eyelet. Biochem J 2003 0.87
53 New antibiotic molecules: bypassing the membrane barrier of gram negative bacteria increases the activity of peptide deformylase inhibitors. PLoS One 2009 0.86
54 Efflux mechanism, an attractive target to combat multidrug resistant Plasmodium falciparum and Pseudomonas aeruginosa. Curr Med Chem 2009 0.86
55 Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. PLoS One 2011 0.86
56 Antibiotic uptake through membrane channels: role of Providencia stuartii OmpPst1 porin in carbapenem resistance. Biochemistry 2012 0.84
57 Propyl paraben induces potassium efflux in Escherichia coli. J Antimicrob Chemother 2005 0.83
58 4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain. Int J Antimicrob Agents 2003 0.83
59 Ethidium bromide efflux by Salmonella: modulation by metabolic energy, pH, ions and phenothiazines. Int J Antimicrob Agents 2011 0.83
60 New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity. J Antimicrob Chemother 2012 0.83
61 pH Modulation of efflux pump activity of multi-drug resistant Escherichia coli: protection during its passage and eventual colonization of the colon. PLoS One 2009 0.83
62 Structure, Function and Regulation of Outer Membrane Proteins Involved in Drug Transport in Enterobactericeae: the OmpF/C - TolC Case. Open Microbiol J 2013 0.83
63 Use of the omp50 gene for identification of Campylobacter species by PCR. J Clin Microbiol 2004 0.83
64 Expression and purification of native and truncated forms of CadF, an outer membrane protein of Campylobacter. Int J Biol Macromol 2006 0.83
65 Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria. J Antimicrob Chemother 2010 0.82
66 Production of the cryptic EefABC efflux pump in Enterobacter aerogenes chloramphenicol-resistant mutants. J Antimicrob Chemother 2006 0.81
67 Antibiotic-resistant Campylobacter: could efflux pump inhibitors control infection? J Antimicrob Chemother 2006 0.81
68 Overexpression and purification of the three components of the Enterobacter aerogenes AcrA-AcrB-TolC multidrug efflux pump. J Chromatogr B Analyt Technol Biomed Life Sci 2003 0.81
69 Chemosensitizers in drug transport mechanisms involved in protozoan resistance. Curr Drug Targets Infect Disord 2005 0.81
70 Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. Int J Antimicrob Agents 2006 0.80
71 New peptides with metal binding abilities and their use as drug carriers. Bioconjug Chem 2014 0.80
72 Polyamino geranic derivatives as new chemosensitizers to combat antibiotic resistant gram-negative bacteria. Bioorg Med Chem 2013 0.80
73 A Simple Method for Assessment of MDR Bacteria for Over-Expressed Efflux Pumps. Open Microbiol J 2013 0.79
74 The Enterobacter aerogenes outer membrane efflux proteins TolC and EefC have different channel properties. Biochim Biophys Acta 2007 0.78
75 Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin. Bioorg Med Chem 2012 0.78
76 An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates. Microbiology 2010 0.78
77 Conjugation of a new series of dithiocarbazate Schiff base Copper(II) complexes with vectors selected to enhance antibacterial activity. Bioconjug Chem 2014 0.78
78 Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria. Eur J Med Chem 2011 0.78
79 The omp50 gene is transcriptionally controlled by a temperature-dependent mechanism conserved among thermophilic Campylobacter species. Res Microbiol 2008 0.77
80 Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2009 0.77
81 Computer simulation of spermine-porin channel interactions. In Vivo 2002 0.77
82 Chromosomal His-tagging: an alternative approach to membrane protein purification. Proteomics 2007 0.77
83 Prevalence of efflux activity in low-level macrolide-resistant Campylobacter species. J Antimicrob Chemother 2006 0.75
84 Expression of the adeB gene and responsiveness to 1-(1-naphthylmethyl)-piperazine and phenylalanyl-arginyl-β-naphthylamide in clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 2013 0.75
85 Corrigendum: A unique peptide deformylase platform to rationally design and challenge novel active compounds. Sci Rep 2017 0.75
86 Enterobacter gergoviae membrane modifications are involved in the adaptive response to preservatives used in cosmetic industry. J Appl Microbiol 2014 0.75